Inventor
DEQUEANT MARY-LEE
US5 patents
Patents
5 patentsUS11679130B2Jun 20, 2023
Genetically engineered t cells with Regnase-1 and/or TGFBRII disruption have improved functionality and persistence
CRISPR THERAPEUTICS AG1 citations68
US11497773B2Nov 15, 2022
Genetically engineered t cells with regnase-1 and/or TGFBRII disruption have improved functionality and persistence
CRISPR THERAPEUTICS AG2 citations68
US11795238B2Oct 24, 2023
Anti-idiotype antibodies targeting anti-CD70 chimeric antigen receptor
CRISPR THERAPEUTICS AG0 citations59
US11857574B2Jan 2, 2024
Genetically engineered T cells with Regnase-1 and/or TGFBRII disruption have improved functionality and persistence
CRISPR THERAPEUTICS AG0 citations58
US11679131B2Jun 20, 2023
Genetically engineered T cells with regnase-1 and/or TGFBRII disruption have improved functionality and persistence
CRISPR THERAPEUTICS AG0 citations58